Oppenheimer 25th Annual Consumer Growth and E-Commerce Conference June 11, 2025 1:30 PM ETCompany ParticipantsBrandon J.

Oppenheimer raised its price target on CME Group Inc. (NASDAQ:CME) to $300 from $282, maintaining an Outperform rating, as ...

The median call among 17 banks and investment groups is for the index to end the year at 5950 points, 0.3% lower than ...

The latest price target for CME Group (NASDAQ:CME) was reported by UBS on April 25, 2025. The analyst firm set a price target for $305.00 expecting CME to rise to within 12 months (a possible 5.55 ...

Analysts have set 12-month price targets for CME Group, revealing an average target of $276.38, a high estimate of $305.00, ...

Stocks saw early pressure Friday as concern about US trade policy weighs on market sentiment.  Late Thursday, US Treasury Secretary Bessent said that trade talks with China were "a bit stalled" and ...

On May 29, Oppenheimer analyst Brian Schwartz lowered the firm’s price target on Salesforce, Inc. (NYSE:CRM) to $370 from $380 on group multiple compression but maintained an Outperform rating.

We believe Target’s management team has executed flawlessly by threading the needle between trendy product offerings and low price and has laid the foundation for the firm to potentially warrant ...

Oppenheimer recently raised the price target on Analog Devices, Inc. (NASDAQ:ADI) to $265 from $225 and kept an Outperform rating on the shares ahead of quarterly results. ADI designs ...

Oppenheimer recently raised the price target on Analog Devices, Inc. (NASDAQ:ADI) to $265 from $225 and kept an Outperform rating on the shares ahead of quarterly results. ADI designs, manufactures, ...

On Thursday, Oppenheimer maintained an Outperform rating on Salesforce.com (NYSE: CRM) but reduced the price target to $370 from $380, still representing significant upside from the current price of ...